| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.44 | 9e-27 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-09 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-09 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-06 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |